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microRNAs (miRNAs) constitute a unique class of endogenous small non-coding RNAs that regulate gene expression 
post-transcriptionally. Studies over the past decade have uncovered a recurring paradigm in which miRNAs are key regulators 
of cellular behavior under various physiological and pathological conditions. Most surprising is the recent observation that 
miRNAs have emerged as competent players in somatic cell reprogramming, suggesting an especially significant role for these 
small RNAs in cell fate settings. Here, we discuss the possible mechanisms underlying miRNA-mediated cell programming 
(i.e., the development and differentiation of embryonic stem cells) and reprogramming (i.e., turning somatic cells into pluripo-
tent stem cells or other lineages), and provide a “Helm” model of miRNAs in cell fate decision and conversion.  
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The discovery of microRNA (miRNA) has opened up a new 
view of biosystems because it revealed an unexpected, but 
huge, RNA world hidden in the genome [1]. Unlike mes-
senger RNAs (mRNAs), ribosomal RNAs (rRNAs), or 
transfer RNAs (tRNAs) that directly take part in protein 
biosynthesis, miRNAs [2] and other small RNAs [3], or 
large non-coding RNAs which were found later [4], primar-
ily function as regulatory molecules and modulate the ex-
pression of genes at multiple levels, directly or indirectly. 
Today, it is widely recognized that a complicated “RNA 
regulatory network” controls many, if not all, gene activities 
within a cell, including DNA and histone modification, 
structural dynamics of chromosome, gene transcription, 
RNA processing, transport, protein synthesis, and degrada-
tion [5].  
One major characteristic of miRNAs that makes them 
ideal regulators of cell activities, like transcription factors, 
is the ability of a single miRNA to directly control the ex-
pression of hundreds of genes to execute entire cellular or 
organ programs [6]. With miRNA roles identified in devel-
opmental timing, cell death, cell proliferation, hematopoie-
sis, and neuronal patterning [7], as well as in various human 
diseases, including cancers, cardiovascular diseases, neuro-
degeneration, diabetes, and viral infection [8], evidence is 
mounting that animal miRNAs are more numerous, and that 
their regulatory impact is more pervasive, than was previ-
ously suspected. Particularly, the most stunning example is 
that miRNAs help to orchestrate developmental events 
throughout embryonic development by regulating the tem-
poral transitions in gene expression associated with cell fate 
progression and differentiation, which is well-characterized 
in lower animals such as Caenorhabditis elegans [9].  
Recent years have seen rapid advances in the field of cell 
reprogramming, specifically in the conversion of kinds of 
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somatic cells into pluripotent stem cells or into other line-
ages by defined factors [10,11]. Most striking is the obser-
vation that the ability to drive these transitions is not limited 
to transcription factors, but that they can be achieved by 
miRNAs as well [12,13]. Understanding the mechanisms of 
miRNA-based reprogramming may provide further insights 
into fundamental questions regarding cell plasticity, cell 
identity and cell fate decisions [14]. Here, rather than at-
tempting to present a comprehensive survey of the numer-
ous studies that have linked miRNAs to cell programming 
and reprogramming, we primarily focus on the unique mo-
dality by which miRNAs specify cell fate and discuss the 
influence of different miRNA families on the establishment 
and maintenance of cell identity. 
1  miRNAs promote programs that define the 
fate and characteristics of developing cells  
Development is an extremely complex and highly pro-
grammed process, by which a single zygote undergoes 
growth, fate determination, differentiation, morphogenesis, 
and finally forms an intact organism. From the day it was 
discovered in 1993, miRNA has been tightly linked to 
stage-specific cell fates during embryonic development 
[15,16]. It was really amazing that loss of the single miRNA 
lin-4, or even its binding site on lin-14, resulted in signifi-
cant developmental defects in C. elegans [15,16]. There is 
no better support for the importance of miRNAs in devel-
opment than this evidence. However, the significance of 
these tiny RNAs was not recognized until 2000, when the 
second miRNA, let-7, was detected and its sequence and 
temporal expression was shown to be highly conserved 
across a wide range of animal species [17,18]. The exten-
sive tiny RNA world was further revealed by the identifica-
tion of approximately 100 miRNA genes in worms, flies, 
and human cells in 2001 [19–21].  
The global requirement for miRNAs in embryogenesis is 
evidenced by the genetic disruption of Dicer [22–24], an 
RNase III-family nuclease that is essential for miRNA bio-
genesis [25]. While loss of Dicer1 in mice leads to lethality 
early in development with the depletion of stem cells [22], 
zebrafish that lack both maternal and zygotic Dicer activity 
(known as MZdicer mutants) undergo axis formation and 
differentiate into multiple cell types but display abnormal 
morphogenesis during gastrulation, brain formation, somi-
togenesis, and heart development [24]. Although Dicer has 
also been implicated in the biogenesis of endogenous small 
interfering RNAs (siRNAs) [26], many of the defects in 
MZdicer mutants are rescued by mature miRNA injection, 
suggesting that the phenotypes are indeed due to an absence 
of miRNA function [24]. Considering the dual involvement 
of Dicer, other researchers deleted Dgcr8, which encodes an 
RNA-binding protein that is specifically required for miR-
NA processing [27]. In striking contrast to Dicer, the loss of 
zygotic Dgcr8 in mice led to embryonic arrest prior to E6.5 
but did not impair preimplantation development, indicating 
that miRNAs primarily play regulatory roles in postimplan-
tation development [28,29].  
Although the mechanism for how individual miRNAs 
exert their specific roles during development is not fully 
understood, it is clear that miRNAs are primarily associated 
with the establishment and maintenance of cell identity, as 
Plasterk and colleagues [30] have provided pictures like 
artwork that show the temporal and spatial expression pat-
terns of 115 conserved vertebrate miRNAs in zebrafish em-
bryos by microarrays and in situ hybridizations. In the past 
10 years, overwhelming experimental studies have evi-
denced the role of miRNAs in promoting the programs that 
define the fate and characteristics of developing cells in 
diverse cellular systems [7,31,32]. In particular, a few of 
miRNAs highly specifically expressed in certain tissues or 
cell-lineages are more prominent in regulating cell fate, 
such as miR-1 [33–35], miR-133 [34–36], miR-223 [37,38], 
miR-124 [39–42], and miR-122 [43–46]. Almost all of these 
studies indicate that tissue-specific miRNAs play critical 
roles in promoting lineage-specific differentiation by di-
rectly targeting some key regulatory genes [32]. For exam-
ple, the muscle-specific miR-1 regulates cardiogenesis by 
targeting Hand2 [33], whereas miR-1 promotes myogenesis 
by targeting histone deacetylase 4 (HDAC4) [34]. The my-
eloid-specific miR-223 regulates progenitor proliferation 
and granulocyte differentiation by the repression of the 
transcription factors NFI-A [37] and Mef2c [38]. The neu-
ron-specific miR-124 promotes neuronal differentiation by 
triggering brain-specific alternative pre-mRNA splicing 
through targeting polypyrimidine tract binding protein 1 
(PTBP1) [40]. Additionally, miR-124 antagonizes the an-
ti-neural REST/SCP1 pathway during the development of 
the embryonic central nervous system (CNS) [42]. The liv-
er-specific miR-122 inhibits the proliferation and promotes 
the differentiation of hepatocytes during liver development 
by targeting cut-like homeobox 1 (CUTL1) [43]. Moreover, 
several tissue-specific miRNAs, such as miR-1, miR-133, 
miR-145, miR-143, and miR-9, have been shown to help 
refine and limit gene expression during lineage commitment 
of embryonic stem cells (ESCs) [35,47–49], suggesting that 
miRNAs may have general utility in regulating cell-fate 
decisions from pluripotent ESCs.  
Notably, the requirement of individual miRNAs for dif-
ferentiation, growth, and organogenesis during development 
is not equal. For example, Horvitz and colleagues [50] gen-
erated mutant C. elegans strains that each lack multiple or 
all members of one of the 15 miRNA families; however, 
they were surprised to find that mutants for 12 of these fami-
lies did not display strong synthetic abnormalities, suggest-
ing that some miRNA families have subtle roles during de-
velopment. The data from miRNA-knockout studies in mice 
are also consistent with this observation [51]. The impact of 
individual miRNA knockouts on mouse heart development 
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is widely studied, and a dozen miRNA families have been 
investigated so far [51]. The deletion of miR-1-2 in mice 
causes ~50% lethality due to ventricular septal defects 
(VSDs), in spite of only a 50% reduction in the overall level 
of miR-1 expression in these mice [52]. Although mice 
lacking either miR-133a-1 or miR-133a-2 genes do not dis-
play obvious cardiac abnormalities, the deletion of both 
genes results in ~56% lethality due to VSDs and chamber 
dilatation [53]. The deletion of the miR-17–92 cluster also 
causes perinatal lethality due to VSDs [54]. The deletion of 
endothelial cell-specific miR-126 results in ~40% lethality 
due to vascular developmental defects [55,56]. In contrast, 
mice lacking miR-208a [57,58] or miR-145 [59] were viable 
but with different degrees of heart defects. However, no 
apparent phenotype was observed in mice that lacked 
miR-208b [60], miR-499 [60], miR-143 [59], the miR-106a– 
363 cluster [54], or the miR-106b–25 cluster [54]. Interest-
ingly, consistent with the data that were obtained from in 
vitro studies, it has been suggested that tissue-specific and 
highly abundant miRNAs, such as miR-1, miR-133, and 
miR-126, are essential for the development of their associ-
ated tissues and organs; moderately abundant miRNAs are 
secondary but required, whereas other miRNAs with lower 
expression levels may be unnecessary.  
2  Reprogramming the somatic cells into plu-
ripotent cells or other lineages by miRNAs  
Whereas “program” in biology stands for a series of devel-
opmental and differentiation processes that are orderly ar-
ranged in the life cycle of an organism, “reprogram” is the 
reversal of programming, which refers to the erasure and 
remodeling of the functional state of the genome, resulting 
in the conversion of a differentiated cell to an immature cell 
(pluripotent) or the transit directly from one lineage to an-
other (lineage reprogramming) [61]. Although it has been 
studied more than 50 years and remarkable breakthroughs 
were obtained [62–64], only in recent years has cellular 
reprogramming attracted unprecedented attention, especial-
ly after Yamanaka and colleagues [65,66] reported that fi-
broblasts can be induced into pluripotent stem cells (iPS 
cells) by the forced expression of four transcription factors 
(OCT4, KLF4, MYC and SOX2, which are collectively 
called OKMS). Cellular reprogramming has been achieved 
by many approaches, such as nuclear transfer, cell fusion, 
long-term in vitro cell culture, forced expression of tran-
scription factors [67], and, most recently, by the introduc-
tion of miRNAs [13]. However, compared with other tradi-
tional approaches such as nuclear transfer and cell fusion, 
the ectopic expression of defined factors has obvious ad-
vantages in technical operability and simplicity, which 
makes it more attractive. From 2006 to the present, accu-
mulating studies have witnessed the success and progress in 
cellular reprogramming by the forced expression of tran-
scription factors [10,11,68] and/or miRNAs [14,69]. Several 
representative studies in which both transcription factors 
and miRNAs were employed are schematically shown in 
Figure 1. 
After the recognition of the key roles of miRNAs in 
cell-fate decision during embryonic development and cellu-
lar differentiation, it is not surprising that they are currently 
emerging as competent players in somatic cell reprogram-
ming [70–72]. In particular, all of the miRNAs that are spe-
cifically and/or abundantly expressed in ESCs have also 
been shown to induce or promote pluripotency [69,73]. 
ESCs express a distinctive set of miRNAs, which are re-
quired for the establishment and maintenance of ESC iden-
tity [73,74]. The majority of these miRNAs are derived 
from two polycistronic clusters: the miR-302–367 cluster 
(miR-302a/b/c/d and miR-367) and, in mice, the miR-290–    
295 cluster (miR-290, miR-291a, miR-291b, miR-292, 
miR-293, miR-294 and miR-295) or, in humans, the 
miR-371–373 cluster (miR-371, miR-372 and miR-373) 
[75,76]. Significantly, these ESC-specific miRNAs possess 
the same or similar ‘seed’ sequence, and thus, are predicted 
to cooperatively regulate downstream targets [77,78]. These 
ESC-specific miRNAs account for as much as 60%–70% of 
the total miRNAs that are expressed in ESCs [77–80]. It has 
been shown that the miR-302–367 cluster is among the 
most significantly upregulated miRNAs in both human 
ESCs and iPS cells compared with fibroblasts [81]. Thus, 
these ESC-specific miRNAs can strongly promote or di-
rectly induce the reprogramming of somatic cells to pluripo-
tency [70–72,82–84]. Mechanistically, these miRNAs have 
been shown to regulate various cellular processes, including 
cell cycle, differentiation, mesenchymal-to-epithelial transi-
tion (MET), epigenetic regulation, cell signaling and vesic-
ular transport [82,85–91], all of which are critical for the 
establishment and maintenance of pluripotency.  
Another notably important miRNA family that promotes 
iPS is the miR-17 family, which is not ESCs-specific but is 
enriched in pluripotent cells [77,78]. One of the main de-
fects in miRNA-null ESCs is a reduced proliferation rate, as 
shown in Dgcr8/ ESCs [28]. A functional screen identified 
several miRNAs that were able to rescue this defect, which 
are primarily transcribed from the ESC-specific miR-290– 
295 and miR-302–367 clusters, as well as four miRNAs 
from the miR-17 family [85]. The miR-17 family consists of 
three paralogous polycistronic clusters on different chromo-
somes: miR-17–92 (miR-17, miR-18a, miR-19a, miR-20a, 
miR-19b-1, and miR-92a-1), miR-106b–25 (miR-106b, 
miR-93, and miR-25), and miR-106a–363 (miR-106a, 
miR-18b, miR-20b, miR-19b-2, miR-92a-2, and miR-363) 
[92]. Several members of this family were shown to be 
highly induced during early reprogramming and greatly 
enhanced the induction of iPS cells [93], most likely by 
regulating cell cycle progression [85,94,95] and the MET 
step in the initiation stage of reprogramming [93].  
Apart from these so-called ESCC miRNAs (ESC-specific  
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Figure 1  miRNAs that are involved in cell reprogramming. The schematic illustrates the most studied cell types in somatic cell reprogramming, including 
iPS cells, neurons, cardiomyocytes and hepatocytes. The first three cell types have been successfully reprogrammed from fibroblasts, either by transcription 
factors or miRNAs that are specifically expressed in certain cell types. Reprogrammed hepatocytes have also been successfully generated by the enforced 
expression of transcription factors. Although unverified, miR-122 is expected to have the potential to convert fibroblasts into hepatocytes and is therefore 
shown in gray letters. Similarly, miR-124 is expected to be capable of reprogramming hepatocytes into neurons and is also shown in gray.  
cell cycle-regulating miRNAs) [85], many other miRNA 
families also facilitate iPS [69,96]. The miR-200 family 
(miR-200a, miR-200b, miR-200c, miR-141 and miR-429) 
and miR-205 are shown to be induced during the initiation 
phase of reprogramming, which stimulate MET and pro-
mote mouse embryonic fibroblast (MEF) reprogramming, 
probably by targeting Zeb1, Zeb2, Snail and Slug [97,98]. 
Significantly, mir-200c, combined with mir-302 and 
mir-369 family miRNAs, has been shown to successfully 
induce the reprogramming of mouse and human cells to 
pluripotency [72]. A functional miRNA screen identified 
the miR-130 family (miR-130/301/721), which enhanced 
iPS generation through targeting the homeobox transcrip-
tion factor Meox2 (also known as Gax) [99]. miR-138 is 
shown to promote iPS generation through the regulation of 
the p53 signaling pathway [100]. Recently, miR-29b has 
been shown to be a mediator of Sox2 function and is re-
quired for OSKM-mediated reprogramming through target-
ing Dnmt3a and Dnmt3b [101]. However, miR-29a was 
previously shown to negatively regulate iPS [102]. This 
difference might be cell context-dependent and should be 
further investigated.  
In addition to the miRNA families that are enriched in 
pluripotent cells, there are also several miRNA families that 
are expressed at significantly lower levels in pluripotent 
cells than in differentiated cells and thus play a negative role 
in iPS generation [69]. The most remarkable one is the let-7 
family, a group of well-known differentiation-promoting 
miRNAs that are highly enriched in differentiated cells 
compared with ESCs and iPS cells [77,81]. Coincidentally, 
in contrast to ESC-specific miRNAs, the let-7 family targets 
Lin-28, c-Myc, N-Myc and many other pluripotent genes to 
inhibit ESC self-renewal and promote differentiation [88]. 
Additionally, a group of miRNAs, which include miR-134, 
miR-296, miR-470 [103], miR-145 [48] and the miR-34 
family [104], directly target different pluripotent transcrip-
tion factors (OCT4, SOX2, KLF4, Nanog, N-Myc, etc.) and 
therefore provide a barrier for the reprogramming to plurip-
otency. In addition, miR-199 [105], miR-21 and miR-29a 
[102] have also been shown to inhibit reprogramming. 
Moreover, a few miRNAs, such as the miR-23 family 
(miR-23a, miR-23b, miR-27a, miR-27b) and miR-143, are 
significantly downregulated in pluripotent cells and are 
therefore expected to inhibit somatic cell reprogramming 
[81].  
Direct lineage reprogramming (also known as transdif-
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ferentiation) was first observed 25 years ago [63], and has 
become one of the most attractive fields in cell biology and 
regenerative medicine [106]. Recent studies have demon-
strated that a diverse range of cell types, such as pancreatic 
 cells [107], neurons [108,109], cardiomyocytes [110–112], 
and hepatocytes [113,114], can be directly induced from 
somatic cells using cocktails of transcription factors. Re-
markably, an important breakthrough was made in 2010, 
when, for the first time, transdifferentiation across germ 
layers-conversion of mouse fibroblasts (mesoderm) to neu-
rons (ectoderm) was achieved [108]. Similar to that in the 
reprogramming of pluripotent cells, transcription factors are 
widely employed in the induction of transdifferentiation and 
the number of successful studies is constantly increasing 
[61,115]. Interestingly, two groups of tissue-specific miRNAs 
have been shown to accomplish this mission as excellently 
as transcription factors [116,117]. Crabtree and colleagues 
[116] showed that miR-124 and miR-9/9* alone, which are 
selectively expressed in post-mitotic neurons, could induce 
the conversion of fibroblasts to neurons. This exciting suc-
cess is based on their previous finding that miR-124 and 
miR-9* play a critical role in neural development by the 
repression of BAF53a and thereby mediate a switch of 
chromatin-remodeling complexes [118]. In addition, miR-      
124 cooperates with two transcription factors (MYT1L and 
BRN2), which are able to reprogram fibroblasts to func-
tional neurons [119]. In the latter instance, a combination of 
four cardiomyocytes-specific miRNAs, miR-1, miR-133, 
miR-208, and miR-499, is capable of inducing the direct 
cellular reprogramming of fibroblasts to cardiomyocyte-like 
cells [117]. Recently, it has been shown that four human 
cardiac transcription factors, including GATA4, Hand2, 
T-box5, and myocardin, and two miRNAs, miR-1 and 
miR-133, are necessary and sufficient for the direct myo-
cardial reprogramming of human fibroblasts [120]. Alt-
hough successful instances of transdifferentiation mediated 
by miRNAs are currently few, some other tissue-specific 
miRNAs are also expected to be capable of promoting 
transdifferentiation to their respective cell types. Among the 
most promising candidates is hepatocyte-specific miR-122, 
which has been shown to activate the expression of several 
hepatocyte functional genes in a hepatoblastoma cell    
line [43].  
Recently, a remarkable study demonstrated that the re-
pression of a single RNA-binding polypyrimidine tract-      
binding (PTB) protein is sufficient to induce the transdif-
ferentiation of multiple cell types of diverse origin into 
neuronal-like cells or even functional neurons [121]. This 
unsuspected phenomenon appears to be due to the relief of a 
PTB-mediated blockade the action of miRNA (miR-124) on 
several components of the REST (RE1-silencing transcrip-
tion factor) complex and the subsequent derepression of 
neuronal-specific genes and genes that encode miRNAs 
[121]. Interestingly, the authors further provide evidence 
that the knockdown of SCP1 or REST is sufficient to trigger 
the transdifferentiation of MEFs into neuronal-like cells 
[121]. Therefore, this finding suggests that a conserved reg-
ulatory network, which is constituted by lineage-specific 
miRNAs, transcription factors, and epigenetic regulators, as 
well as other unrecognized factors, functions across diverse 
cell types; therefore, the artificial alteration of one of these 
factors might mediate cell reprogramming.  
3  Modality by which miRNAs specify a cell fate 
How is a specific cell state regulated by hundreds of mi-   
RNAs? Using ESCs as a model, we will demonstrate this 
mechanism because the miRNA expression profiles, func-
tions, and targets, all have been well-studied in ESCs. Based 
on the aforementioned evidence, we provide a “Helm” model 
of the role of miRNAs in the establishment and maintenance 
of cellular homeostasis (Figure 2). According to this model, 
the cell identity (function and fate) of a given cell is con-
trolled by a series of balances between miRNAs and their 
targets. The status of each miRNA family is associated with 
their relative abundance in the cells, as illustrated in Figure 2.  
Several characteristics should be noted in this model. (i) 
The unity of “yin and yang”. All the miRNA families can be 
divided into three groups on the basis of their attitude to the 
present state: positive, negative and neutral. miRNAs that 
are essential for the establishment and maintenance of cur-
rent state are positive members (“yang”), whereas miRNAs 
that inhibit the current state are negative members (“yin”), 
leaving miRNAs that do not influence the current state as 
the neutral members. In ESCs, the miR-302 family (the 
miR-302367 cluster, the miR-371373 cluster, and the 
miR-290-295 cluster in mice), the miR-17 family (the 
miR-1792 cluster, the miR-106b25 cluster and the 
miR-106a363 cluster), the miR-200 family, the miR-130 
family, miR-138, etc., which promote pluripotency, are 
“yang”. In contrast, tissue-specific miRNAs, such as 
miR-124/9, miR-1/133, and miR-122, the let-7 family, the 
miR-34 family, miR-145, miR-134, miR-296, miR-470, 
miR-199, etc., which promote differentiation and inhibit 
pluripotency, are “yin”. Correspondingly, the “yin and 
yang” of target genes is opposite to miRNAs. For example, 
the pluripotent transcription factors OCT4, SOX2, KLF4, 
Nanog and N-Myc are targets of miR-145 or the miR-34 
family, and accordingly are “yang”. (ii) The dose-dependent 
effect. Each balance has a unique tendency, which is de-
pendent on the relative level of both miRNAs and their tar-
gets. When miRNAs are highly abundant, such as the 
miR-302 family, their targets are fully repressed and the 
balance tends to miRNAs. In addition, the miR-1792 clus-
ter is relatively enriched, and therefore, their targets are 
significantly repressed. In contrast, when miRNAs are ex-
pressed at low levels or silenced, such as tissue-specific 
miRNAs and the let-7 family, their targets are fully ex-
pressed and the balance tends to target proteins. Moreover,  
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Figure 2  The Helm model showing the weight of different miRNA families in controlling the cell fate, using miRNAs that are involved in regulating the 
pluripotency and differentiation of ESCs as examples. ESCs express hundreds of miRNAs that work synergistically to direct the “course” of ESCs and to 
keep ESCs on the route of pluripotency, by a series of balances between miRNAs and their targets. However, the contribution of each miRNA family to 
pluripotency is different. Because of its overwhelming abundance, the miR-302 family takes the helm of ESCs. The next enriched family is the miR-17 fam-
ily, which serves as “the mate” and escort for pluripotency. Other miRNA families, such as the miR-200 family, the miR-130 family and miR-138, also 
facilitate pluripotency by regulating different targets. In contrast, some miRNA families that are highly expressed in somatic cells but are expressed at low 
levels or silenced in ESCs can be regarded as “opposition”, which directly or indirectly inhibit pluripotency. Tissue-specific miRNAs, such as miR-124/9, 
miR-1/133, and miR-122, are the predominant miRNA families in specific somatic cells (neurons, muscles, and hepatocytes, respectively) and consequently 
lead the “opposition”. The let-7 family miRNAs are highly enriched in most somatic cells and thus are important forces in the “opposition”. The miR-34 
family, miR-143, miR-145, miR-134, miR-296, miR-470, miR-199, etc. also set obstacles for pluripotency. The hairpins in the red triangles represent miR-
NAs, and the green ovals in blue triangles represent target proteins. Gradient colors of balls indicate the relative expression levels for each miRNA family: 
blue, low; gray, mean; red, high. 
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there are some balances in which the expression of both 
miRNAs and their targets are moderate, and thus, the bal-
ance is level. (iii) Different weights. The importance and 
contribution of each miRNA family are not equal. Highly 
enriched miRNAs usually play a dominant role in the estab-
lishment and maintenance of the current cell state, whereas 
the contribution of miRNAs that are expressed at signifi-
cantly lower levels might be negligible. Many examples 
have been discussed in the text above. (iv) Independence 
and interaction. The regulation of each balance may be in-
dependent. However, changes in some critical balances may 
have a significant impact on the other balances through 
cross-talk. For example, the role of the miR-302 family is 
oppositely related to the let-7 family, and therefore, they 
could indirectly repress the expression of each other. (v) 
Homeostasis is changeable. When the dominant miRNA 
families are substituted by specific miRNAs in other cell 
types, as observed in miRNA-mediated lineage transdiffer-
entiation and iPS, the cell fate could be reprogrammed and a 
new homeostasis will form.  
All of this evidence points to the distinctive importance 
of miRNAs that are specifically and abundantly expressed 
in specific cells. There are several possible reasons that may 
explain why the functional role in development and cell 
reprogramming has been primarily ascribed to the most en-
riched miRNAs. First, there is an obvious dosage require-
ment for miRNAs to efficiently repress the expression of 
target genes, as evidenced by the phenomenon that almost 
all target genes are gradually downregulated with the in-
creased level of related miRNAs [33,43]. Second, an abun-
dance of copies of mature miRNAs also seems to be re-
quired for the direct repression of a large number of genes 
[122]. Third, tissue-specific miRNAs are expected to regu-
late switch genes specifying the cell fate and developmental 
timing because many transcription factors, particularly 
transcription repressors, have been shown to be targeted by 
tissue-specific miRNAs [33,34,37,42,43]. Last, tissue-      
specific miRNAs are generally woven into the principal 
regulatory network, which is constituted by enriched tran-
scription factors and the dominant signaling pathway 
[43,123,124].  
4  Conclusion and perspectives 
Whereas a programmed life cycle is a great masterpiece of 
natural evolution over billions of years, cell reprogramming, 
with its promising application in regenerative medicine, is a 
creative result of human civilization. Although small, 
miRNAs have a high potential for use in cell reprogram-
ming for the following reasons. First, miRNAs can be syn-
thesized by high-throughput and easily introduced into a 
variety of cell types by transfection, significantly reducing 
the technical requirements. Second, using mature miRNAs 
only transiently can eliminate the risks and concerns of pos-
sible genomic disruption by viral integration. Last, most 
lineage-specific miRNAs in adult tissues have been shown 
to play a tumor-suppressing role; thus, the oncogenesis po-
tentiated by gene overexpression can be reduced.  
Understanding the molecular mechanisms that underlie 
programming and reprogramming processes is crucial for 
the creation of high-quality reprogrammed cells and may be 
useful for therapeutic applications [125]. Despite the great 
advances obtained, we are only about to understand the 
molecular basis of these processes, primarily because it is 
currently challenging to decipher the functional targets of 
miRNAs which usually regulate a large number of genes to 
modulate biological networks. Fortunately, newly devel-
oped high-throughput RNA capturing and sequencing tech-
nologies may assist in determining the key targets of miR-
NAs from hundreds of candidates [126–128]. For example, 
using Argonaute CLIP-Seq (sequencing of RNAs isolated 
by crosslinking immunoprecipitation), Darnell and col-
leagues [126] provided the first in vivo miRNA-mRNA in-
teraction map in mouse brain and identified a large tar-
get-network that may account for the regulatory role of 
miR-124. Two independent groups studied the genome-       
wide miRNA-target interactions in mouse and human ESCs, 
respectively, and identified a large group of targets of 
ESC-specific miRNA families [129,130]. Functional studies 
identified novel roles of the miR-302 family in maintaining 
pluripotency and in regulating hESC differentiation, partly 
through promoting the bone morphogenetic protein (BMP) 
signaling [130], which is also necessary for the MET during 
the initiation phase of somatic cell reprogramming [97].  
Waddington’s concept of the ‘epigenetic landscape’ has 
served as an educative hierarchical model to illustrate the 
progressive restriction of cell differentiation potential dur-
ing normal development [131]. However, this concept fails 
to explain the success in somatic cell reprogramming. Most 
recently, Brüstle and colleagues have proposed a non-     
hierarchical ‘epigenetic disc’ model in which the pluripotent 
state is just one of many possible states, which is not any 
higher in hierarchy than other cell states and, therefore, can 
be bypassed in the process of cell fate conversion [14]. 
Consistent with this viewpoint, our “Helm” model also im-
plies that cell fate is controlled in the hands of a few highly 
enriched miRNAs; therefore, cell fate can theoretically be 
converted by the substitution of the predominating miRNA 
families with lineage-specific miRNAs in target cells. 
However, this prospect should be further explored by exten-
sive investigations.  
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